In this report, our team offers a comprehensive analysis of Clinical Next-Generation Sequencing market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain,market statistics in terms of revenue, sales, price, capacity, regional market analysis,segment-wise data,and market forecast information are offered in the full study, etc.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Roche
Pacific Bioscience
Agilent Technologies
Macrogen
Oxford Nanopore
Foundation Medicine
Life technologies
Exosome Diagnostics
CLC Bio
Paradigm
Partek
GnuBIO
Caris Life Sciences
Others
...
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Targeted Sequencing
Exome Sequencing
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Clinical Next-Generation Sequencing Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Targeted Sequencing
1.3.2 Exome Sequencing
1.4 Application Overview
1.4.1 Hospitals and Clinics
1.4.2 Biopharma Companies
1.4.3 Academic and Research Organizations
1.4.4 Others
1.5 Industrial Chain
1.5.1 Clinical Next-Generation Sequencing Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Targeted Sequencing
2.1.2 Exome Sequencing
2.2 The Overall Market Performance(Value)
2.2.1 Targeted Sequencing
2.2.2 Exome Sequencing
3 Global Clinical Next-Generation Sequencing Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Hospitals and Clinics
3.3 Biopharma Companies
3.4 Academic and Research Organizations
3.5 Others
4 Competitive Analysis
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Profiles
4.1.2 Thermo Fisher Scientific Product Information
4.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Performance
4.1.4 SWOT Analysis
4.2 PerkinElmer
4.2.1 PerkinElmer Profiles
4.2.2 PerkinElmer Product Information
4.2.3 PerkinElmer Clinical Next-Generation Sequencing Business Performance
4.2.4 SWOT Analysis
4.3 Illumina
4.3.1 Illumina Profiles
4.3.2 Illumina Product Information
4.3.3 Illumina Clinical Next-Generation Sequencing Business Performance
4.3.4 SWOT Analysis
4.4 Beckman Coulter
4.4.1 Beckman Coulter Profiles
4.4.2 Beckman Coulter Product Information
4.4.3 Beckman Coulter Clinical Next-Generation Sequencing Business Performance
4.4.4 SWOT Analysis
4.5 GATC Biotech
4.5.1 GATC Biotech Profiles
4.5.2 GATC Biotech Product Information
4.5.3 GATC Biotech Clinical Next-Generation Sequencing Business Performance
4.5.4 SWOT Analysis
4.6 Qiagen
4.6.1 Qiagen Profiles
4.6.2 Qiagen Product Information
4.6.3 Qiagen Clinical Next-Generation Sequencing Business Performance
4.6.4 SWOT Analysis
4.7 Roche
4.7.1 Roche Profiles
4.7.2 Roche Product Information
4.7.3 Roche Clinical Next-Generation Sequencing Business Performance
4.7.4 SWOT Analysis
4.8 Pacific Bioscience
4.8.1 Pacific Bioscience Profiles
4.8.2 Pacific Bioscience Product Information
4.8.3 Pacific Bioscience Clinical Next-Generation Sequencing Business Performance
4.8.4 SWOT Analysis
4.9 Agilent Technologies
4.9.1 Agilent Technologies Profiles
4.9.2 Agilent Technologies Product Information
4.9.3 Agilent Technologies Clinical Next-Generation Sequencing Business Performance
4.9.4 SWOT Analysis
4.10 Macrogen
4.10.1 Macrogen Profiles
4.10.2 Macrogen Product Information
4.10.3 Macrogen Clinical Next-Generation Sequencing Business Performance
4.10.4 SWOT Analysis
4.11 Oxford Nanopore
4.12 Foundation Medicine
4.13 Life technologies
4.14 Exosome Diagnostics
4.15 CLC Bio
4.16 Paradigm
4.17 Partek
4.18 GnuBIO
4.19 Caris Life Sciences
4.20 Others
5 Competitive Lanscape
5.1 Global Clinical Next-Generation Sequencing Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Clinical Next-Generation Sequencing Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Clinical Next-Generation Sequencing Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Clinical Next-Generation Sequencing Market Assessment by Regions
7.1 Global Clinical Next-Generation Sequencing Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Clinical Next-Generation Sequencing Price (USD/Unit) by Regions (2014-2020)
7.5 Global Clinical Next-Generation Sequencing Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.2 China Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.3 USA Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.4 Europe Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.5 Japan Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.6 Korea Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.7 India Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
8.9 South America Clinical Next-Generation Sequencing Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Clinical Next-Generation Sequencing Major Manufacturers
11 Global Clinical Next-Generation Sequencing Market Forecast by Regions
11.1 Global Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.1.1 Global Clinical Next-Generation Sequencing Capacity Forecast by Regions (2021-2026)
11.1.2 Global Clinical Next-Generation Sequencing Sales Forecast by Regions (2021-2026)
11.1.2 Global Clinical Next-Generation Sequencing Revenue Forecast by Regions (2021-2026)
11.2 China Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.3 USA Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.4 Europe Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.5 Japan Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.6 Korea Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.7 India Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.8 Southeast Asia Clinical Next-Generation Sequencing Market Forecast (2021-2026)
11.9 South America Clinical Next-Generation Sequencing Market Forecast (2021-2026)
12 Global Clinical Next-Generation Sequencing Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Targeted Sequencing
12.3 Exome Sequencing
13 Global Clinical Next-Generation Sequencing Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 Hospitals and Clinics
13.3 Biopharma Companies
13.4 Academic and Research Organizations
13.5 Others
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Clinical Next-Generation Sequencing Average Price Forecast (2021-2026)
14.2 Global Clinical Next-Generation Sequencing Gross Profit Forecast (2021-2026)
15 Conclusion